top of page

Pathogenic Cellular Proliferation
(Cancer)

Cancer as a disease name is a poor descriptor of what is happening and is a bad conceptual understanding of what is actually going on.

 

What is actually happening is: pathogenic cellular proliferation, and it looks like this:

​

​

​

​

​

​

​

​

​

​

​

​

​

​​​​​

Approximately 28,800 people die per day from pathogenic cellular proliferation globally, and that is roughly

one (1) death every three (3) seconds*.
 

As of 2022, every year, approximately 2,100,000 people are diagnosed with pathogenic cellular proliferation in America and Canada [1, 2].
 

Approximately 35% of people will not survive five (5) years from their initial diagnosis [1, 2].


Every day approximately 1,900 Americans and Canadians die of pathogenic cellular proliferation [1, 2].
 

Globally, that number is roughly 1,200 people per hour.


Imagine a machine that makes just one anti-cancer drug work 100% more effective.
What impact would that machine have on people's lives and the lives of their families?

Imagine a machine that can make two anti-cancer drugs work 100% more effective.

What about three drugs?

Or Four?

That machine is
a chemotherapeutic galvanostat/potentiostat and it was invented 2009. 

​

- - -

​

Due to Canadian politics:
157,680,000 people are dead from pathogenic cellular proliferation since the CGP was invented in 2009*.

​

That's 1.9% of the total population of the planet Earth dead to date*.

​

*Calculation derived from data sources with 1 and 2.

1. American Cancer Society. Cancer Facts & Figures 2022, Atlanta: American Cancer Society; 2022.

​

2. Canadian Cancer Statistics Advisory Committee in collaboration with the Canadian Cancer Society, Statistics Canada and the Public Health Agency of Canada. Canadian Cancer Statistics 2021. Toronto, ON: Canadian Cancer Society; 2021.

​

​

Innovative Potential - Cancer Biology Wheel - 10-11-2022.png
Innovative%2520Potential%2520-%2520Logo_edited_edited.png

© Innovative Potential Inc., L.L.C., 2018-2025.
Est. 2016

bottom of page